87 related articles for article (PubMed ID: 16929516)
1. Impact of cyclins E, neutrophil elastase and proteinase 3 expression levels on clinical outcome in primary breast cancer patients.
Desmedt C; Ouriaghli FE; Durbecq V; Soree A; Colozza MA; Azambuja E; Paesmans M; Larsimont D; Buyse M; Harris A; Piccart M; Martiat P; Sotiriou C
Int J Cancer; 2006 Dec; 119(11):2539-45. PubMed ID: 16929516
[TBL] [Abstract][Full Text] [Related]
2. Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients.
Sieuwerts AM; Look MP; Meijer-van Gelder ME; Timmermans M; Trapman AM; Garcia RR; Arnold M; Goedheer AJ; de Weerd V; Portengen H; Klijn JG; Foekens JA
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3319-28. PubMed ID: 16740753
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer cell uptake of the inflammatory mediator neutrophil elastase triggers an anticancer adaptive immune response.
Mittendorf EA; Alatrash G; Qiao N; Wu Y; Sukhumalchandra P; St John LS; Philips AV; Xiao H; Zhang M; Ruisaard K; Clise-Dwyer K; Lu S; Molldrem JJ
Cancer Res; 2012 Jul; 72(13):3153-62. PubMed ID: 22564522
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of polymorphonuclear leukocyte elastase in patients with primary breast cancer.
Foekens JA; Ries C; Look MP; Gippner-Steppert C; Klijn JG; Jochum M
Cancer Res; 2003 Jan; 63(2):337-41. PubMed ID: 12543785
[TBL] [Abstract][Full Text] [Related]
5. Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with β-cell autoimmunity in patients with type 1 diabetes.
Wang Y; Xiao Y; Zhong L; Ye D; Zhang J; Tu Y; Bornstein SR; Zhou Z; Lam KS; Xu A
Diabetes; 2014 Dec; 63(12):4239-48. PubMed ID: 25092677
[TBL] [Abstract][Full Text] [Related]
6. Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin.
Kessenbrock K; Fröhlich L; Sixt M; Lämmermann T; Pfister H; Bateman A; Belaaouaj A; Ring J; Ollert M; Fässler R; Jenne DE
J Clin Invest; 2008 Jul; 118(7):2438-47. PubMed ID: 18568075
[TBL] [Abstract][Full Text] [Related]
7. Using a Caesalpinia echinata Lam. protease inhibitor as a tool for studying the roles of neutrophil elastase, cathepsin G and proteinase 3 in pulmonary edema.
Cruz-Silva I; Neuhof C; Gozzo AJ; Nunes VA; Hirata IY; Sampaio MU; Figueiredo-Ribeiro Rde C; Neuhof H; Araújo Mda S
Phytochemistry; 2013 Dec; 96():235-43. PubMed ID: 24140156
[TBL] [Abstract][Full Text] [Related]
8. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
[TBL] [Abstract][Full Text] [Related]
9. Identification of a three-gene expression signature of poor-prognosis breast carcinoma.
Bièche I; Tozlu S; Girault I; Lidereau R
Mol Cancer; 2004 Dec; 3(1):37. PubMed ID: 15606925
[TBL] [Abstract][Full Text] [Related]
10. Unopposed cathepsin G, neutrophil elastase, and proteinase 3 cause severe lung damage and emphysema.
Guyot N; Wartelle J; Malleret L; Todorov AA; Devouassoux G; Pacheco Y; Jenne DE; Belaaouaj A
Am J Pathol; 2014 Aug; 184(8):2197-210. PubMed ID: 24929239
[TBL] [Abstract][Full Text] [Related]
11. Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer.
Müller-Tidow C; Metzger R; Kügler K; Diederichs S; Idos G; Thomas M; Dockhorn-Dworniczak B; Schneider PM; Koeffler HP; Berdel WE; Serve H
Cancer Res; 2001 Jan; 61(2):647-53. PubMed ID: 11212263
[TBL] [Abstract][Full Text] [Related]
12. High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis.
Barbareschi M; Maisonneuve P; Aldovini D; Cangi MG; Pecciarini L; Angelo Mauri F; Veronese S; Caffo O; Lucenti A; Palma PD; Galligioni E; Doglioni C
Cancer; 2003 Aug; 98(3):474-83. PubMed ID: 12879463
[TBL] [Abstract][Full Text] [Related]
13. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.
Girault I; Lerebours F; Amarir S; Tozlu S; Tubiana-Hulin M; Lidereau R; Bièche I
Clin Cancer Res; 2003 Apr; 9(4):1259-66. PubMed ID: 12684393
[TBL] [Abstract][Full Text] [Related]
14. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
Steppich BA; Seitz I; Busch G; Stein A; Ott I
Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma.
Shen Z; Wen XF; Lan F; Shen ZZ; Shao ZM
Clin Cancer Res; 2002 Jul; 8(7):2085-90. PubMed ID: 12114407
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases.
Takano Y; Kato Y; van Diest PJ; Masuda M; Mitomi H; Okayasu I
Am J Pathol; 2000 Feb; 156(2):585-94. PubMed ID: 10666388
[TBL] [Abstract][Full Text] [Related]
17. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil elastase and proteinase 3 trafficking routes in myelomonocytic cells.
Källquist L; Rosén H; Nordenfelt P; Calafat J; Janssen H; Persson AM; Hansson M; Olsson I
Exp Cell Res; 2010 Nov; 316(19):3182-96. PubMed ID: 20828556
[TBL] [Abstract][Full Text] [Related]
19. [miR-497 suppresses proliferation of human cervical carcinoma HeLa cells by targeting cyclin E1].
Han J; Huo M; Mu M; Liu J; Zhang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):597-600. PubMed ID: 24909281
[TBL] [Abstract][Full Text] [Related]
20. Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome.
Vuaroqueaux V; Urban P; Labuhn M; Delorenzi M; Wirapati P; Benz CC; Flury R; Dieterich H; Spyratos F; Eppenberger U; Eppenberger-Castori S
Breast Cancer Res; 2007; 9(3):R33. PubMed ID: 17535433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]